Connect with us

Forex

Forex Market Still Subdued as China Posts Huge GDP Fall

mm

Updated

 on

  • EUR/USD and Others Show no Significant Movement
  • China Announces Record GDP Decline
  • Trump Outlines Re-Opening Plans amid Drug Results Boost

Another difficult week for the forex market is coming to a close with little in the way of positive movement. The EUR/USD market still languished below the 1.09 mark early on Friday. This comes even as European stocks reacted positively on encouraging results from drug trials carried out by US firm Gilead Sciences. Traders may be reacting tentatively on the back of Chinas record GDP fall earlier on Friday.

Major Forex Markets Holding Back on Mixed News

Despite early gains across the board in European markets, the Euro and GBP have both struggled to make any significant moves early in the day. Forex trading markets have been slow to make any movements likely due to a lack of certainty on a day that has brought mixed news. The suffering of Asian markets earlier in the day is now being counteracted by a boost in European stocks.

This mixed news has likely left forex traders in two minds as to their next move, and deciding to adopt a more risk-off strategy moving into the weekend. Forex brokers may see more action throughout the day or into Monday as the news on potentially positive drug trials brings traders back to the market. For the moment though, it seems everyone is taking a moment to digest the main news stories of the day.

Biggest Fall in Chinese GDP Since 1992

China posted the biggest drop in its GDP since official records of the number began in 1992. The Q1 drop of 6.8% came in slightly above what analysts had predicted. This comes in much expected fashion since the country has suffered from major shutdowns since the Lunar New Year in January. Retail sales also fell 19% as shoppers stayed home together with the rest of the nation.

As the country still struggles to return to work following the coronavirus outbreak, experts are predicting that growth for 2020 overall will slow considerably. This number is expected to come in at around 2.5% for 2020. This would be a big drop from the 6.1% gains posted in 2019. With the outbreak far from over, there is still much concern globally that these numbers could fall even more in the coming months.

Drug Trials Provide a Hint of Optimism

Both European and American markets jumped in early trading on news that trials from American drug makers Gilead Sciences have shown positive results in rapidly reducing fever and respiratory symptoms in COVID19 patients. The company posted a share price increase of more than 16% on the news.

At the same time, President Trump has released a three-stage plan for the country to get back to work. The plan may pave the way for some states to reopen if they show a downward trajectory in cases and positive tests in the previous 14-days before enacting the plan.

[table “14” not found /]

 

 

Anthony is a financial journalist and business advisor with several years’ experience writing for some of the most well-known sites in the Forex world. A keen trader turned industry writer, he is currently based in Shanghai with a finger on the pulse of Asia’s biggest markets.

Advertiser Disclosure: Securities.io is committed to rigorous editorial standards to provide our readers with accurate reviews and ratings. We may receive compensation when you click on links to products we reviewed.

ESMA: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Investment advice disclaimer: The information contained on this website is provided for educational purposes, and does not constitute investment advice.

Trading Risk Disclaimer: There is a very high degree of risk involved in trading securities. Trading in any type of financial product including forex, CFDs, stocks, and cryptocurrencies.

This risk is higher with Cryptocurrencies due to markets being decentralized and non-regulated. You should be aware that you may lose a significant portion of your portfolio.

Securities.io is not a registered broker, analyst, or investment advisor.